Hiroyuki Arai1, Andrew Elliott2, Joanne Xiu2, Jingyuan Wang1, Francesca Battaglin1, Natsuko Kawanishi1, Shivani Soni1, Wu Zhang1, Joshua Millstein3, Davendra Sohal4, Richard M Goldberg5, Michael J Hall6, Aaron J Scott7, Moh'd Khushman8, Jimmy J Hwang9, Emil Lou10, Benjamin A Weinberg11, John L Marshall11, Albert C Lockhart12, Phillip Stafford13, Jian Zhang13, Roberto Moretto14, Chiara Cremolini15, W Michael Korn16, Heinz-Josef Lenz17. 1. Division of Medical Oncology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California. 2. Clinical and Translational Research, Medical Affairs, Caris Life Sciences, Phoenix, Arizona. 3. Department of Preventive Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California. 4. Division of Hematology/Oncology, University of Cincinnati, Cincinnati, Ohio. 5. West Virginia University Cancer Institute, Morgantown, West Virginia. 6. Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania. 7. Department of Medicine, University of Arizona Cancer Center, Tucson, Arizona. 8. Medical Oncology, Mitchell Cancer Institute, The University of South Alabama, Mobile, Alabama. 9. Department of Solid Tumor Oncology, GI Medical Oncology, Levine Cancer Institute, Charlotte, North Carolina. 10. Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota. 11. Ruesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC. 12. Department of Medicine, Division of Oncology, University of Miami, Miller School of Medicine, Miami, Florida. 13. Department of Bioinformatics, Caris Life Sciences, Phoenix, Arizona. 14. Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy. 15. Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. 16. Medical Affairs, Caris Life Sciences, Phoenix, Arizona. 17. Division of Medical Oncology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California. lenz@usc.edu.
Authors: Michael Cerniglia; Joanne Xiu; Axel Grothey; Michael J Pishvaian; Yasmine Baca; Jimmy J Hwang; John L Marshall; Ari M VanderWalde; Anthony F Shields; Heinz-Josef Lenz; W Michael Korn; Mohamed Salem; Philip A Philip; Richard M Goldberg; Jia Zeng; Sunnie S Kim Journal: Mol Cancer Ther Date: 2021-11-01 Impact factor: 6.009